39% mean reduction size across 114 biopharma companies is a bad sign for the industry. Some companies, like EQRx, closed the doors. With Big Pharma also having massive layoffs in 2023, the future doesn’t look bright for specialized workforce.
https://www.fiercebiotech.com/biotech/every-bad-signal-theres-good-sign-not-far-behind-biopharma-layoffs-rise-57-yoy-hope-2024